Keeping the FDA Moving Forward Is a Life-or-Death Matter
When Vinay Prasad was tapped to lead the FDA’s Center for Biologics Evaluation and Research, the healthcare world braced for its effect. Known for his critical analyses of the FDA’s accelerated approval processes and calls for more in-depth evidence requirements, his leadership is one that could either bolster or hinder the delicate balance between rigorous regulation and […]
La dérive précautionniste de Robert F. Kennedy Jr.
Partisan du principe de précaution à l’européenne, le ministre de la Santé américain s’attaque à la FDA et freine l’innovation médicale et agricole. Une vision méfiante envers la science industrielle qui pourrait coûter cher à l’économie américaine. Depuis que Robert Kennedy Jr. a pris ses fonctions de ministre de la Santé, il agit exactement comme […]
Undermining American Pharmaceutical Companies Won’t Make Drugs Cheaper
President Donald Trump’s new executive order on prescription drug prices — which he called “one of the most consequential executive orders in our country’s history” — may well live up to the hype, but not in the way Trump intends. Trump’s announcement of a “most favored nation” policy means the United States government will only pay drug prices equal […]
The Three Words RFK Jr. Relies on
It would be a stretch to say that Health and Human Services (HHS) is being led for the first time by someone who is out of their depth, but it’s certainly the case that, for the first time, its chief is deeply suspicious of most modern medicine. Since Robert F. Kennedy Jr.’s confirmation as HHS […]
Trump’s drug price EO gets headlines, but will it make a difference?
President Trump says his landmark executive order seeking to reign in prescription drug prices will result in immediate savings for Americans, but some groups think price controls could stymie innovation. Bill Wirtz of the Consumer Choice Center weighs in on “The Final 5 with Jim Lokay.” Watch the interview here
Trump’s Drug Price Controls Could Ground Innovation To a Halt
Americans are notoriously unhappy with healthcare. As of last December, Americans’ perception of the quality of US healthcare hit a new low, with 54% of the population reporting to Gallup that quality is either fair or poor. Coverage is viewed even more poorly than quality, and it has slowly brought the Republican Party of President Trump to […]
Drug Prices Are High, But Trump’s Order Could Crush Medical Innovation
Americans are notoriously unhappy with healthcare. As of last December, Americans’ perception of the quality of US healthcare hit a new low, with 54% of the population reporting to Gallup that quality is either fair or poor. Coverage is viewed even more poorly than quality, and it has slowly brought the Republican Party of President Trump to […]
Consumer Choice Center Warns: Drug Price Controls Will Cost Lives Tomorrow
The Consumer Choice Center strongly opposes the Trump administration’s executive order to impose drug price controls through a Most Favored Nation (MFN) pricing scheme, warning that it threatens future innovation and patient access to life-saving treatments. The MFN model, which ties U.S. drug prices to those set by foreign governments, undermines American leadership in pharmaceutical […]
